Ocuphire Pharma, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ocuphire Pharma, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Ocuphire Pharma, Inc. Return On Equity for the quarter ending June 30, 2024 was -30.2 %, a 155% decline year-over-year.
  • Ocuphire Pharma, Inc. annual Return On Equity for 2023 was -22.3 %, a 128% decline from 2022.
  • Ocuphire Pharma, Inc. annual Return On Equity for 2022 was 79.5 %.
  • Ocuphire Pharma, Inc. annual Return On Equity for 2021 was -302 %, a 223% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -30.2 -84.6 -155% Apr 1, 2024 Jun 30, 2024
Q1 2024 -24.6 -90.2 -137% Jan 1, 2024 Mar 31, 2024
Q4 2023 -22.3 -102 -128% Oct 1, 2023 Dec 31, 2023
Q3 2023 65.5 +201 Jul 1, 2023 Sep 30, 2023
Q2 2023 54.5 +173 Apr 1, 2023 Jun 30, 2023
Q1 2023 65.6 +183 Jan 1, 2023 Mar 31, 2023
Q4 2022 79.5 +381 Oct 1, 2022 Dec 31, 2022
Q3 2022 -136 +564 +80.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -118 +2.67K +95.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -118 -1.23K -111% Jan 1, 2022 Mar 31, 2022
Q4 2021 -302 -547 -223% Oct 1, 2021 Dec 31, 2021
Q3 2021 -700 -762 -1220% Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.78K -2.97K -1600% Apr 1, 2021 Jun 30, 2021
Q1 2021 1.11K +1.4K Jan 1, 2021 Mar 31, 2021
Q4 2020 245 +319 Oct 1, 2020 Dec 31, 2020
Q3 2020 62.5 +162 Jul 1, 2020 Sep 30, 2020
Q2 2020 186 +340 Apr 1, 2020 Jun 30, 2020
Q1 2020 -296 -113 -61.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -73.1 +112 +60.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -99.8 +20 +16.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -155 -82.4 -114% Apr 1, 2019 Jun 30, 2019
Q1 2019 -183 -146 -397% Jan 1, 2019 Mar 31, 2019
Q4 2018 -185 +22.1 +10.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -120 +60.9 +33.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -72.4 +115 +61.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -36.7 +172 +82.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -207 -152 -274% Oct 1, 2017 Dec 31, 2017
Q3 2017 -181 -113 -168% Jul 1, 2017 Sep 30, 2017
Q2 2017 -187 -114 -155% Apr 1, 2017 Jun 30, 2017
Q1 2017 -209 -133 -175% Jan 1, 2017 Mar 31, 2017
Q4 2016 -55.3 +15.5 +21.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -67.4 -5.71 -9.26% Jul 1, 2016 Sep 30, 2016
Q2 2016 -73.6 -27.1 -58.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -75.9 -45.8 -152% Jan 1, 2016 Mar 31, 2016
Q4 2015 -70.8 -5.52 -8.46% Oct 1, 2015 Dec 31, 2015
Q3 2015 -61.7 +14.8 +19.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -46.5 +48.9 +51.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -30.1 +131 +81.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -65.3 +39.3 +37.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -76.5 +5.74 +6.98% Jul 1, 2014 Sep 30, 2014
Q2 2014 -95.4 +13.8 +12.7% Apr 1, 2014 Jun 30, 2014
Q1 2014 -161 -87.1 -117% Jan 1, 2014 Mar 31, 2014
Q4 2013 -105 -23.1 -28.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -82.2 -9.39 -12.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -109 -63.4 -138% Apr 1, 2013 Jun 30, 2013
Q1 2013 -74.1 +14.1 +16% Jan 1, 2013 Mar 31, 2013
Q4 2012 -81.4 Oct 1, 2012 Dec 31, 2012
Q3 2012 -72.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 -45.8 Apr 1, 2012 Jun 30, 2012
Q1 2012 -88.3 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.